NASDAQ NMS - GLOBAL MARKET · PALI
+8.18% · +$0.1300 · Vol 3.6M
Market closed · last close 4:00 PM ET · price as of 18:13:19 ET
Palisade Bio Inc

Palisade Bio Inc

Biotechnology
$1.72
Card
Relationship Map

Follow $PALI

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $PALI by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
PALI
Palisade Bio Inc
Mon Sep 21 · market closed · Markets closed · resumes Tue 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

45/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Mon Sep 21 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PALI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PALI catalysts
About Palisade Bio Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
14
Country
US

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.64
Day high
$1.69
Day low
$1.60
Previous close
$1.59
52W high
$2.80
-38.57% from high
52W low
$0.6324
50% of range
Market cap
$277.1M
EPS
$-1.0600
Beta
1.67
Shares out
174.3M
Volume
3.6M
1.46× rel vol
Avg volume
2.4M
VWAP
$1.67
Price history computed in-house
1W
-14.64%
1M
-18.10%
3M
-10.42%
1Y
+170.91%
YTD
-26.81%
SMA 50 $2.00 · below
SMA 200 $1.93 · below
52W position 50%

PALI overview

Veridion Score
45
Registered · 2026-09-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PALI.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PALI Form 4 filings
Public disclosures

Congress activity in PALI

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PALI in the cached public ledger.

Federal contracts

PALI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PALI in this window.
Lobbying spend

PALI lobbying filings, year to date.

Registered lobbying filings matched to Palisade Bio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PALI in this window.
Loading news for PALI
Analyst ratings
Sovereign unlock shows live analyst consensus for PALI.
Options
Sovereign unlock shows live options positioning for PALI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.